These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 16884385)
1. Integrated 18F-fluorodeoxyglucose positron emission tomography and computerized tomography in endodermal sinus tumor. Klieger C; Dvir R; Even-Sapir E; Lessing JB; Burstein Y; Grisaru D Int J Gynecol Cancer; 2006; 16(4):1685-8. PubMed ID: 16884385 [TBL] [Abstract][Full Text] [Related]
2. Advanced extragonadal yolk sac tumor serially followed up with (18)F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein. Baba T; Su S; Umeoka S; Abiko K; Nakamoto Y; Mandai M; Matsumura N; Konishi I J Obstet Gynaecol Res; 2012 Mar; 38(3):605-9. PubMed ID: 22353601 [TBL] [Abstract][Full Text] [Related]
3. Occult Mediastinal Yolk Sac Tumor Producing α-Fetoprotein Detected by 18F-FDG PET/CT. Liu M; Chen G; Fu Z; Li Z; Li Q Clin Nucl Med; 2016 Jul; 41(7):585-6. PubMed ID: 27088388 [TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760 [TBL] [Abstract][Full Text] [Related]
5. AFP-producing hepatoid adenocarcinoma of appendix: a case report of 18F-FDG PET/CT. Wang XY; Bao WQ; Hua FC; Zuo CT; Guan YH; Zhao J Clin Imaging; 2014; 38(4):526-528. PubMed ID: 24721022 [TBL] [Abstract][Full Text] [Related]
6. Primary Pancreatic Yolk Sac Tumor Presenting as Diffusely Enlarged Pancreas in Initial 18F-FDG PET/CT. Sui H; Zhu Z; Li Z; Luo Y Clin Nucl Med; 2020 Jun; 45(6):483-486. PubMed ID: 32332317 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT. Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794 [TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT Evaluation of Pediatric Patients With Yolk Sac Tumor. Tang W; Liu Z; Fu H; Li C; Wang H AJR Am J Roentgenol; 2019 Sep; 213(3):676-682. PubMed ID: 31120780 [No Abstract] [Full Text] [Related]
9. Carcinosarcoma of the uterine corpus on 18F-FDG PET/CT in a postmenopausal woman with elevated AFP. Chen F; Yu C; You X; Mi B; Wan W Clin Nucl Med; 2014 Sep; 39(9):803-5. PubMed ID: 24152629 [TBL] [Abstract][Full Text] [Related]
10. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736 [TBL] [Abstract][Full Text] [Related]
11. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
12. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845 [TBL] [Abstract][Full Text] [Related]
13. Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases. Takahashi M; Kanamori Y; Takahashi M; Momose T; Iwanaka T Surg Today; 2014 Oct; 44(10):1962-5. PubMed ID: 23801057 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833 [TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up. Ostermeier A; McCarville MB; Navid F; Snyder SE; Shulkin BL Pediatr Radiol; 2015 Aug; 45(9):1308-15. PubMed ID: 25721584 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
17. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging. Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498 [TBL] [Abstract][Full Text] [Related]
18. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255 [TBL] [Abstract][Full Text] [Related]
20. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]